Introduction
NAFLD prevalence in India varies widely, ranging from 6.7% to 55.1% in adults and 7.3% to 22.4% in children. It is strongly associated with metabolic conditions such as:
- Obesity
- Type 2 diabetes
- Dyslipidemia
- Hypertension
- Cardiovascular disease
Globally, NAFLD affects approximately 25.2% of adults, with higher prevalence in regions like the Middle East and South America.
Aim and Methodology
Aim
To understand the prevalence of NAFLD in both global and Indian populations.
Methods
Data was extracted from multiple published studies focusing on NAFLD prevalence across demographics and geographies.
Global Burden of NAFLD
Overall Global Prevalence
- Estimated prevalence: ~32% globally
- Higher in men (40%) than women (26%)
- Increasing trend: from 26% (pre-2005) to 38% (post-2016)
Incidence Trends
- Global incidence: ~47 cases per 1,000 people
- Higher incidence in men than women
Regional Distribution of NAFLD
Asia
- Average prevalence: ~30%
- Southeast Asia highest (~42%)
- Country variations:
- Iran: ~40%
- China: ~32%
- Japan: ~22%
Europe
- Prevalence: ~30–32%
- Highest in Turkey (~48%)
- Lower in Mediterranean countries (~23.9%)
North America
- Prevalence: ~35.3%
- Higher among Hispanics due to genetic and metabolic factors
South America
- Prevalence: up to ~59%
- Driven by obesity, diabetes, and genetic predisposition
Africa
- Variable prevalence: 13.5% to 56.8%
- Limited data availability
NAFLD in India
General Population
- Prevalence range: 9% to 53%
- Higher in urban populations
- Rural prevalence can be as low as ~8.7%
Urban vs Rural Trends
- Urban prevalence: up to 53.7%
- Strong link with metabolic syndrome and lifestyle factors
NAFLD in Children
Prevalence
- India: 7.3% to 22.4%
- Global: 9% to 37%
Risk Factors
- Obesity and overweight
- Insulin resistance
- Dyslipidemia
- Family history
Key Insights
- Overweight children: up to 80% prevalence
- Rising childhood obesity is a major driver
NAFLD in the Elderly
Prevalence Trends
- Ages 60–69: ~28.9%
- Ages 70–79: ~34%
- Declines after age 80
Age-Related Liver Changes
- Reduced liver function and blood flow
- Increased fibrosis risk
- Higher susceptibility to drugs and toxins
Clinical Implications
- Increased mortality risk
- Greater likelihood of cardiovascular complications
Key Risk Factors for NAFLD
- Obesity and central adiposity
- Type 2 diabetes
- Insulin resistance
- Dyslipidemia
- Sedentary lifestyle
- Genetic predisposition
Limitations of the Study
- Based only on available published literature
- Regional data gaps exist, especially in developing regions
Conclusion
NAFLD is a major global health concern and a leading cause of chronic liver disease in both India and worldwide. Key projections include:
- Up to 33% prevalence by 2030
- Nearly 50% of adults affected by 2040
Rising trends are driven by aging populations, increasing obesity, and metabolic disorders. Early prevention through:
- Healthy diet
- Regular physical activity
- Weight management
- Positive lifestyle changes
is critical to reducing disease burden and preventing progression to severe liver conditions.
References
(Condensed for blog readability; full citations available upon request)
- Shalimar et al., 2022
- Singhai et al., 2023
- Teng et al., 2023
- De & Duseja, 2021
- Das et al., 2017
- Pitisuttithum et al., 2022
- Gan et al., 2011
